AngioDynamics to Present at the J.P. Morgan Healthcare Conference
21 December 2022 - 8:01AM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative
medical technology company focused on restoring healthy blood flow
in the body’s vascular system, expanding cancer treatment options
and improving quality of life for patients, today announced that
Jim Clemmer, President and Chief Executive Officer, and Stephen
Trowbridge, Executive Vice President and Chief Financial Officer,
will present at the J.P. Morgan 41st Annual Healthcare Conference
at 8:15 a.m. PT (11:15 a.m. ET) on Thursday, January 12, 2023 in
San Francisco, CA.
A live webcast of the presentation will be accessible through
the “Investors” section of the Company’s website at
www.angiodynamics.com and will be available for replay following
the event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology
company focused on restoring healthy blood flow in the body’s
vascular system, expanding cancer treatment options and improving
quality of life for patients.
The Company’s innovative technologies and devices are chosen by
talented physicians in fast-growing healthcare markets to treat
unmet patient needs. For more information, visit
www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221220005691/en/
Investor Contact: AngioDynamics, Inc. Stephen Trowbridge,
Executive Vice President & CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024